Thus, consistently with its activity as an apoptosis inhibitor observed in osteosarcoma, SENP5 mediates resistance to therapy, and on these bases, the inhibition of SENP5 may represent a possible strategy for the disease treatment. The gene discussed is SENP5; the disease is osteosarcoma.